Condensed Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flow from operating activities:
Net loss	$ (1,341,847)	$ (2,176,369)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	18,574	21,040
Vested stock options and warrants	587,444	37,775
Issuance of common stock in cashless warrant exchange		468,158
Loss on Sales of Equipment		145
Gain from sale of marketable securities	(1,837)
Changes in assets and liabilities:
Accounts receivable	(29,587)	(14,495)
Inventories	23,022	(24,791)
Prepaid expense and other assets	(11,645)	100,690
Accounts payable	(140,848)	141,271
Accrued expenses	(265,893)	(141,306)
Deferred Revenue	6,409
Net cash used in operating activities:	(1,156,208)	(1,587,882)
Cash flow from investing activities:
Purchase of marketable securities		(800,000)
Proceeds from sale of marketable securities	284,665
Purchase of certificates of deposit	(2,593,985)	(1,000,000)
Purchase of fixed assets	(26,898)	(17,387)
Purchase of intangibles	(194)	(1,424)
Net cash used in investing activities:	(2,336,412)	(1,818,811)
Cash flow from financing activities:
Issuance of common stock	3,814,938	86,253
Net cash provided by (used in) financing activities	3,814,938	86,253
Net increase (decrease) in cash	322,318	(3,320,440)
Cash at beginning of period	1,764,090	4,856,232
Cash at end of period	$ 2,086,408	$ 1,535,792